Diagnosis of Pompe's disease in cultured skin fibroblasts and primary amniotic fluid cells using 4-methylumbelliferyl-alpha-D-glucopyranoside as substrate.

doi:10.1016/0009-8981(77)90325-4

Paper

Diagnosis of Pompe's disease in cultured skin fibroblasts and primary amniotic fluid cells using 4-methylumbelliferyl-alpha-D-glucopyranoside as substrate.

Published Jul 15, 1977 · J. Butterworth, D. M. Droadhead

Clinica chimica acta; international journal of clinical chemistry

Q1 SJR score

24

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Using 4-methylumbelliferyl-alpha-D-glucopyranoside as substrate for acid -d -glucosidase assay, a clear distinction can be made between carriers and Pompe's cells, allowing for accurate diagnosis of the disease.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Diagnosis of Pompe's disease in cultured skin fibroblasts and primary amniotic fluid cells using 4-methylumbelliferyl-alpha-D-glucopyranoside as substrate.

References

Citations